“…Furthermore, the use of different markers to evaluate circadian characteristics, such as plasma or salivary melatonin levels (Gaspar et al, 2021; Hernández et al, 2007; Papaioannou et al, 2012), expression of a different number of various circadian genes in PBMCs (Burioka et al, 2008; Gabryelska, Sochal, et al, 2020; Gaspar et al, 2021; X. Li et al, 2022; Moreira et al, 2017; Xie et al, 2022; Yang et al, 2019), heart rate variability (Noda et al, 1998), actimetry parameters (Butler et al, 2015), and alterations in hormone levels or inflammatory molecules (Burioka et al, 2008), encumbers the comparison between studies. In regard to sample structure and the small number of control subjects in the majority of studies, it is worth noting that including healthy subjects in sleep studies is challenging due to the limited availability of polysomnography.…”